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Objective: We undertook this study to determine whether thrombin-cleaved osteopontin (OPN) in
synovial ﬂuid (SF) represents a useful marker of osteoarthritis (OA) progression in the posterior cruciate
ligament transection (PCLT) OA rabbit model.
Method: PCLT was performed on the right knee joints of 48 rabbits. The rabbits were then sacriﬁced
separately at 4, 8, 16, and 24 weeks post-surgery, when the joint was harvested and macroscopic and
histological assessments of articular cartilage were performed. Thrombin-cleaved OPN product in SF was
determined using Western blotting and the levels were measured using an enzyme-linked immunoassay.
Results: The macroscopic and histological scores for PCLT knees were already elevated 4 weeks after
surgery and increased with time. Western blotting showed the presence of thrombin-cleaved OPN in SF
from PCLT knees. Thrombin-cleaved OPN levels in SF were elevated at 4 weeks (P < 0.001) and were
elevated peaking at 24 weeks (P < 0.00001) after PCLT compared to baseline. A positive signiﬁcant
correlation was found between thrombin-cleaved OPN levels and the macroscopic scores (8 weeks:
r ¼ 0.695, P ¼ 0.012; 16 weeks: r ¼ 0.751, P ¼ 0.005; 24 weeks: r ¼ 0.660, P ¼ 0.020). Furthermore, the
same correlation was noted between thrombin-cleaved OPN levels and the histological scores (4 weeks:
r ¼ 0.609, P ¼ 0.036; 8 weeks: r ¼ 0.662, P ¼ 0.019; 16 weeks: r ¼ 0.827, P ¼ 0.001; 24 weeks: r ¼ 0.813,
P ¼ 0.001).
Conclusion: In this rabbit model of PCLT, thrombin-cleaved OPN levels in SF appear to provide a useful
marker of OA disease severity and progression.
Crown Copyright  2012 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society
International. All rights reserved.Introduction
Osteoarthritis (OA) is thought to be the most prevalent chronic
joint disease. Worldwide estimates are that about 10% of men and
18% of women and about 60e65% aged over 60 years have symp-
tomatic OA and 80% of those have limitations in movement. Diag-
nosis of OA relies mainly on clinical examination and radiographicto: G.H. Lei, Department of
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012 Published by Elsevier Ltd onmeasures. Radiographic measures, however, are less than adequate
for diagnosing and assessing the actual progress of this disease.
Despite efforts over the past decades to develop markers of disease,
biochemical marker still need to be improved and possibly
extended with more speciﬁc and sensitive methods to diagnose the
disease at an early stage, reliably follow the course of disease and
evaluate efﬁcacy of disease-modifying agents1,2.
Osteopontin (OPN) is an extracellular matrix glycoprotein that
has been recognized as a potential inﬂammatory cytokine. OPN is
abundant in bone and can be secreted by many cell types such as
osteoclasts, macrophages, lymphocytes, epithelial cells and
vascular smooth muscle cells (SMCs)3,4. The function of OPN is
modulated by protease digestion, and a thrombin-cleaved form of
OPN is involved in the pathogenesis of various inﬂammatory
disorders. The biomarker has been studied in vivo in rat5, healthy
human and OA patients6,7 and also rheumatoid arthritis (RA)
patients8. The thrombin-cleaved form of OPN may be involved inbehalf of Osteoarthritis Research Society International. All rights reserved.
Table I
Histochemical/histological assessment of articular cartilage changes
Parameter
Safranin Oefast green staining
0 Uniform staining throughout articular cartilage
1 Loss of staining in superﬁcial zone of hyaline cartilage<50% the length of the
condyle or plateau
2 Loss of staining in superﬁcial zone of hyaline cartilage50% the length of the
condyle or plateau
3 Loss of staining in the upper 2/3’s of hyaline cartilage <50% the length of the
condyle or plateau
4 Loss of staining in the in the upper 2/3’s hyaline cartilage 50% the length of
the condyle or plateau
5 Loss of staining in all the hyaline cartilage <50% the length of the condyle or
plateau
6 Loss of staining in all the hyaline cartilage 50% the length of the condyle or
plateau
Structure
0 Normal
1 Surface irregularities
2 Fissures in <50% surface
3 Fissures in 50% surface
4 Erosion 1/3 hyaline cartilage <50% surface
5 Erosion 1/3 hyaline cartilage 50% surface
6 Erosion 2/3 hyaline cartilage <50% surface
7 Erosion 2/3 hyaline cartilage 50% surface
8 Full depth erosion hyaline cartilage <50% surface
9 Full depth erosion hyaline cartilage 50% surface
10 Full depth erosion hyaline and calciﬁed cartilage to the subchondral bone
<50% surface
11 Full depth erosion hyaline and calciﬁed cartilage to the subchondral bone
50% surface
Chondrocyte density
0 No decrease in cells
1 Focal decrease in cells
2 Multifocal decrease in cells
3 Multifocal conﬂuent decrease in cells
4 Diffuse decrease in cells
Cluster formation
0 Normal
1 <4 clusters
2 4 but <8 clusters
3 8 clusters
Deﬁnitions for the recommended grading system. See glossary in chapter X for
terminology and synonyms. For the purposes of this assessment articular cartilage is
divided into four zones: Zone 1: Superﬁcial zone: upper 1/3 hyaline cartilage; Zone
2: Middle zone: middle 1/3 hyaline cartilage; Zone 3: Deep zone: deep 1/3 hyaline
cartilage; Zone 4: The calciﬁed cartilage. Artifact deﬁnition: ﬁssure but no hypo-
cellularity or loss of safranin O adjacent to the cleft; Focal: observed at one site on
section; Multifocal: observed at more than one site; Multifocal conﬂuent: observed
at multiple sites that are in contact.
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degeneration of articular cartilage8,9.
Surgically induced destabilization of joints is the most widely
used induction method, where the underlying initiating mecha-
nism is altered mechanical loading, one of the most common
causes of secondary OA in humans. Many induction methods
actually copy known injuries in humans, such as anterior cruciate
ligament transection (ACLT) and meniscectomy. As a long-term
complication, many patients with posterior cruciate ligament
(PCL) injuries eventually develop OA in the injured knee joint10,11.
Posterior cruciate ligament transection (PCLT) can also replicate the
naturally occurring sequence of the disease process of human OA
and has been used as a model in previous studies12e15.
The purpose of this study was to investigate the changes over
time of thrombin-cleaved OPN in synovial ﬂuid (SF) during the
development of OA induced by PCLT in rabbits. We hypothesized
that the levels of thrombin-cleaved OPN were correlated with the
macroscopic and histological changes that occurred in this model.
This study aimed at adding important details for the validation of
these speciﬁc OA biomarkers.
Materials and methods
Experimental group
The experiment was absolutely approved by the Institutional
Animal Care and Use Committee of Xiangya Hospital, Central South
University (Changsha, China) and the animals were cared for in the
Experimental Animal Center of Xiangya Hospital. 48 mature white
rabbits (male, 2.5  0.4 kg, 6 months old) were used. The rabbits
were acclimated to conditions for 1 week before the experiment
and were housed individually at 25C with a 12:12-h lightedark
cycle and had free access to tap water and commercial rabbit
diet. Surgical transection of the PCL of the right knee was per-
formed under general anesthesia as previously reported14. Post-
operatively, the rabbits were housed and they had free access to
exercise in a large enclosure. For each rabbit, sodium aminobenzyl
penicillin (500 mg) was administered intramuscularly daily for 7
days postoperatively. The rabbits were sacriﬁced by an intravenous
injection of barbiturates 4, 8, 16 and 24 weeks after the surgical
procedure.
Macroscopic grading
After the rabbits were sacriﬁced, each knee was harvested and
evaluated macroscopically by two independent, blinded investi-
gators using the grading system of Tibesku et al.16, consisting of four
different criteria: ﬁbrillations and ulcerations of the hyaline carti-
lage, osteophyte formation, and joint effusion. Scores for ﬁbrilla-
tions ranged from 0 for intact hyaline cartilage to 3 for marked
ﬁbrillations, scores for ulcerations ranged from 0 for normal to 2 for
a large area of ulceration, scores for osteophyte formation ranged
from 0 for no osteophytes to 3 for marked osteophyte formation,
and scores for joint effusion ranged from 0 for no effusion to 3 for
marked effusion. The total score ranged from 0 to 11, with 0 being
a macroscopically intact knee joint and 11 being signiﬁcant OA.
Histologic grading
Cartilage was removed from the areas of the lesions identiﬁed by
the macroscopic grading and then histologic evaluation was per-
formedonsagittal sectionsof cartilage fromthe lesionsof the femoral
condyles and tibial plateaus. The specimens were dissected, ﬁxed in
4% paraformaldehyde for 2 days. After decalciﬁcation with buffered
ethylene diamine tetraacetic acid (EDTA), the samples thensequentially dehydrated in alcohol and embedded into parafﬁn
blocks. Sections were cut at a thickness of 5 mm, mounted to the
center of the glass slide, deparafﬁnized in xylene, and washed three
times with distilled water and then with Tris-buffered saline for
2 min. Sections were stained with hematoxylin and eosin (H&E) or
with safranin Oefast green to evaluate histologic changes of the
cartilage and bone tissue according to the osteoarthritis research
society international (OARSI) histopathology initiative (Table I)17.This
scale evaluates the severity of OA lesions based on safranin Oefast
green staining (scale 0e6), structure (scale 0e11), chondrocyte
density (scale 0e4), and cluster formation (scale 0e3). The ﬁnal score
corresponds to the score of themost severe lesions. The examination
was performed by two independent researchers in a blind manner.
SF sampling, Western blot analysis and enzyme-linked
immunosorbent assay (ELISA)
SF samples were obtained for each rabbit at baseline, 4, 8, 16 and
24weeks after surgery. 2 ml of sterile Ringer’s solutionwas injected
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samples were centrifuged at 3000 rpm in a micro-centrifuge prior
to freezing and were kept frozen at 70C until the biomarker
analysis was performed.
Western blot analyses of SF were performed to examine the
presence of thrombin-cleaved OPN (OPN N-half). 0.1 ml each
samplewas diluted twicewith phosphate-buffered saline (PBS) and
loaded onto gels, incubated in blocking buffer (PBS, 5% non-fat dry
milk, 0.05% Tween 20) for 1 h at room temperature, washed ﬁve
times with PBS, and then eluted with 1.0 ml of 0.7 M NaCl in PBS.
The elutes were diluted twice with 2 sodium dodecyl sulfate
(SDS) gel-loading buffer (100 mM Tris HCl, pH 6.8, 4% SDS, 20%
glycerol), boiled, and applied onWestern blotting with horseradish
peroxidase (HRP)-labeled rabbit anti-mouse OPN polyclonal anti-
body (O-17) raised against LPVKVTDSGSSEEKLY peptide (Uscnlife
Science & Technology Company, China).
Double-blined quantitative detection of thrombin-cleaved OPN
(OPNN-half) in SF was performed using commercial ELISA (Uscnlife
Science & Technology Company, China) according to the manufac-
turers’ instructions. Brieﬂy, 96-well microtiter plates were coated
with anti-OPN N-half mouse monoclonal antibody (in 0.1 M
carbonate buffer, pH 9.5) at 4C overnight, then blocked with 1%
bovine serum albumin in PBS at 4C overnight. The mouse mono-
clonal antibody (34E3) speciﬁcally reacts to SLAYGLR and SVVYGLR,
exposed by thrombin cleavage of mouse and human OPN, respec-
tively. The wells were then washed seven times with washing
buffer and incubated for 30 min at 4C with a HRP-labeled rabbit
anti-mouse OPN polyclonal antibody (O-17). After nine washes,
substrate solution was added to each well and the plate was
incubated for 30min at room temperature in the dark. Finally, color
development was stopped by addition of stop solution. The optical
density of each sample was measured at 450 nm. Each data was
evaluated by three independent experiments. The assays had intra-
assay coefﬁcients of variation <5% and inter-assay coefﬁcients of
variation <8%18.
Statistical analysis
Macroscopic and histological scores were expressed as
mean  standard deviation (SD). The levels of thrombin-cleavedFig. 1. Histology of cartilage after PCLT in the rabbit knee joint (safranin O/fast green). (a) Ar
observed at baseline. (b) Slight irregularity of the superﬁcial zone was found at 4 weeks p
cellular proliferation were seen at 8 weeks post-surgery. (d) Diffuse loss of chondrocytes in th
of safranine O staining, the loss of articular cartilage and multifocal decrease in cells wereOPN were expressed as median and 95% conﬁdence interval (CI).
Statistical analysis was performed using GraphPad InStat 3. Fried-
man test followed by the Dunn’s multiple comparison post-test was
used to analyze the variation of the biomarker concentration.
Correlations between thrombin-cleaved OPN levels in SF and the
other evaluated parameters were established using the nonpara-
metric Spearman’s rank correlation coefﬁcient. P-values less than
0.05 were taken as statistically signiﬁcant.
Results
Macroscopic and histologic analyses
Macroscopically visible surface ﬁbrillation and focal erosions
were observed as early as 4 weeks after PCLT in the femorotibial
joint. The histological evaluation illustrated the OA lesion observed
with the macroscopic observation (Fig. 1). These characteristics of
OA progressed gradually at later time points, predominantly on the
medial tibial plateau and medial femur. The macroscopic and
histological scores of cartilage from PCLT knees were already
elevated 4 weeks after surgery and increased with time (Table II).
The protein expression of thrombin-cleaved OPN
The protein expressions of thrombin-cleaved OPN are shown in
Fig. 2. In SF, the antibody O-17 reacted with N-half OPN with
molecular weights of 30 kDa. The results showed that samples of SF
contained N-half OPN at baseline showed no band. A faint bandwas
rarely detected at 4 weeks postoperatively. The faint band was
visible at 8 weeks postoperatively. The band was more pronounced
at 16 weeks postoperatively. The strongest band was noted at 24
weeks postoperatively. The protein expression of thrombin-cleaved
OPN was considerably elevated in rabbits with advanced OA.
The levels of thrombin-cleaved OPN
SF levels of thrombin-cleaved OPN are demonstrated in Fig. 3.
The levels of thrombin-cleaved OPN in SF from baseline were 3.20
(95% CI: 1.94e6.71) pmol/L, those from 4 weeks postoperatively
were 9.90 (95% CI: 7.92e13.20) pmol/L, those from 8 weeksticular cartilage with smooth surface, and with regular chondrocytes arrangement was
ost-surgery. (c) Superﬁcial loss of chondrocytes with surface irregularity and sporadic
e whole zone with clone formation was noted at 16 weeks post-surgery. (e) Severe loss
identiﬁed at 24 weeks post-surgery.
Fig. 3. Thrombin-cleaved OPN levels in SF at baseline, 4, 8, 16 and 24 weeks after PCLT.
*P < 0.001 vs baseline; #P < 0.01 vs 4 w; 6P < 0.01 vs 8 w and 16 w.
Table II
Macroscopic and histological evaluation
Macroscopic evaluation Mean ± SD
4 w 1.42  0.90
8 w 3.25  1.54
16 w 5.42  2.19
24 w 7.83  1.75
Histological evaluation Mean ± SD
4 w 4.33  2.23
8 w 9.08  2.81
16 w 15.50  2.15
24 w 18.00  3.86
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from 16 weeks postoperatively were 33.40 (95% CI: 20.27e
46.87) pmol/L, and those from 24 weeks postoperatively were
48.55 (95% CI: 41.62e64.29) pmol/L. The data revealed that
thrombin-cleaved OPN levels from 4, 8, 16, 24 weeks post-
operatively were signiﬁcantly elevated compared with those from
baseline (P < 0.001). Thrombin-cleaved OPN levels in SF were
elevated peaking at 24 weeks after PCLT. There was no statistically
signiﬁcant difference in thrombin-cleaved OPN levels between 8
weeks postoperatively and 16 weeks postoperatively (P ¼ 0.13).
Correlation of SF levels of thrombin-cleaved OPN with macroscopic
and histological scores
At 4 weeks, thrombin-cleaved OPN levels were not correlated
with the macroscopic score (r ¼ 0.482, P ¼ 0.113). Thrombin-
cleaved OPN levels showed a positive correlation with the macro-
scopic scores (8 weeks: r ¼ 0.695, P ¼ 0.012; 16 weeks: r ¼ 0.751,
P ¼ 0.005; 24 weeks: r ¼ 0.660, P ¼ 0.020). Interestingly, the same
correlation was found between thrombin-cleaved OPN levels and
the histological scores (4 weeks: r ¼ 0.609, P ¼ 0.036; 8 weeks:
r ¼ 0.662, P ¼ 0.019; 16 weeks: r ¼ 0.827, P ¼ 0.001; 24 weeks:
r ¼ 0.813, P ¼ 0.001) (Fig. 4).
Discussion
This study revealed a marked increase of thrombin-cleaved OPN
levels in SF after PCLT compared with the baseline. Elevated levels
of OPN in the SF were possibly caused by either the release of OPN
residing in the local tissues, including the synovium, bone, and
articular cartilage, or the increase in its production, or both7,10.
Previous studies have demonstrated the immunohistochemical
expression of OPN in the synovial lining cells19, ﬁbroblasts in the
synovial tissues20 and articular chondrocytes20. It is suggested that
cell adhesion, migration or inﬂammation could be involved in the
release of OPN21. Proinﬂammatory cytokines have been demon-
strated to play a pivotal role in the development of the disease
process. Xu et al.22 reported overexpression of OPN induces
proinﬂammatory chemokines and cytokines (e.g., IL-1, IL-8, CXCL1,
CCL2, and so on) and activates nuclear factor-kappa B pathway.
Sharif et al.8 showed that increased levels of thrombin-cleaved OPN
correlated with increased levels of multiple proinﬂammatory
cytokines including TNF-a and IL-6. Thus, elevated levels ofFig. 2. The protein expression of thrombin-cleaved OPN (OPN N-half) in SF at baseline,
4, 8, 16 and 24 weeks after PCLT detected by Western blot.thrombin-cleaved OPN may play a signiﬁcant role in the patho-
genesis of OA.
Previous study23 also showed administration of an antibody
directed against the SLAYGLR sequence, exposed by thrombin
cleavage of murine OPN, inhibited synovitis, bone erosion, inﬂam-
matory cell inﬁltration in arthritic joints of animalmodels of RA and
reduced the expression of inﬂammatorycytokine (IL-1b, TNF-a, IL-6,
and IL-10). Another very recent study24 showed that the SVVYGLR
sequence induces pro-MMP9 expression in isolated vascular SMCs
and in diabetic mouse aortas. In addition, the SVVYGLR peptide has
been shown to induce angiogenesis of in vitro and in vivo25. These
studies suggested that a SLAYGLR epitope within OPN is involved in
inﬂammatory cell migration, differentiation and activation of oste-
oclast, inﬂammatorycytokineproductionandsynovial proliferation.
However, antibodies recognizing full-length OPN also inhibit
development of arthritis26. Thrombin has various proinﬂammatory
activities, including cytokine release through activation of the
receptors on cells. Tissue factor expression and ﬁbrin deposition are
common features of inﬂamed synovium in RA and OA, which indi-
cates generation of thrombin in the lesions and suggests an
involvement of thrombin in the joint inﬂammation. Sharif et al.8
considered thrombin was generated and cleaves OPN to OPN-R
(SLAYGLR) following initial insult, which enhanced tissue inﬂam-
mation. Alternatively, thrombin can also bind to thrombomodulin
on the synovial cell surface, which then activated thrombin-acti-
vatable procarboxypeptidase B (pCPB) locally to thrombin-activat-
able carboxypeptidase B (CPB) and converted OPN-R (SLAYGLR) to
OPN-L (SVVYGL), thereby dampening inﬂammation. Myles et al.27
found OPN cleavage by thrombin was dependent on both of the
anion-binding exosites in thrombin that determined rates and
speciﬁcity of thrombin proteolysis. Their results suggested OPNwas
a bona ﬁde substrate for thrombin, and generation of thrombin-
cleaved OPN with enhanced proinﬂammatory properties provided
another molecular link between coagulation and inﬂammation.
The intact and thrombin-cleaved forms of OPN (SVVYGLR
sequence) are recognized by a4b1 integrins, while only the
thrombin-cleaved form of OPN (but not intact OPN) binds to a9b1
integrins28. Since synovial ﬁbroblasts express a9b1 integrin and
produce its ligands, OPN and tenascin-C, it is possible that there is
an autocrine and paracrine interaction of a9b1 integrin and its
ligands in vivo29. When a blocking antibody against a9b1 integrin
was given at day 3, the augmented expression of the cytokine (IL-6,
TNF-a, TGF-b, IL-1b) and chemokines (CCL3, CCL4, CXCL5, CXCL12,
Fig. 4. Correlation of SF levels of thrombin-cleaved OPN with macroscopic and histological scores. At 4 weeks, thrombin-cleaved OPN levels were found to be signiﬁcantly
correlated with the histological scores. At 8, 16, 24 weeks, thrombin-cleaved OPN levels were correlated with the macroscopic and histological scores.
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mediated signaling in vivo leads to the production of inﬂammatory
molecules. In addition, bone absorption, a critical outcome of
arthritis, was inhibited by a9b1 integrin antibody treatment28.
These studies indicated the interaction of the cleaved form of OPN
and a9b1 integrin leads to the secretion of cytokine and chemokine,
contributing the development of inﬂammatory tissue destruction.
This mechanism, mediated by thrombin-cleaved OPN, is also likely
to play a key role in OA. Thus, abrogation of the interaction betweencleaved form of OPN or tenascin-C and a9b1 integrin by speciﬁc
antibodies or knock-down of protein or gene expression of OPN,
tenascin-C, or a9b1 integrin by siRNA may be a novel therapeutic
means for the treatment of OA in the future.
We have demonstrated that elevated levels of thrombin-cleaved
OPN in SF correlated with macroscopic and histological scores of
OA. Therefore, only by detecting the levels of thrombin-cleaved
OPN in SF, it may be predictive of the degree of cartilaginous
damage. In accordancewith our observations, Hasegawa et al.9 have
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thrombin-cleaved OPN and disease severity by KellgreneLawrence
grade. Honsawek et al.30 also showed that OPN in plasma and SF
was related to progressive joint damage in knee OA. These ﬁndings
indicate that measurements of synovial levels of thrombin-cleaved
OPN could possibly serve as a biochemical parameter for deter-
mining disease severity and may be predictive of prognosis with
respect to the progression of osteoarthritic disease process.
Matsui et al.5 showed that both structural changes and an
increased loss of proteoglycan from cartilage tissue were
augmented in the absence of OPN. OPN deﬁciency also led to the
induction of matrix metalloproteinase 13 (MMP-13), which
degraded a major component of the cartilage matrix protein type II
collagen. They demonstrated that OPN could be a critical intrinsic
regulator of cartilage degradation and that OPN deﬁciency resulted
in accelerated development of OA-like tenascin-C deﬁciency. Oka-
mura et al.31 revealed that cartilage repair in tenascin-C knockout
mice was signiﬁcantly slower than that in WT mice and that the
deﬁciency of tenascin-C progressed during cartilage degeneration.
Nakoshi et al.32 indicated that the distribution of tenascin-C was
related to chondroitin sulfate production and chondrocyte prolif-
eration in osteoarthritic cartilage and that tenascin-C had effects on
DNA synthesis, proteoglycan content, and aggrecan mRNA
expression in vitro. They considered tenascin-C may be responsible
for repair in human osteoarthritic cartilage. These ﬁndings and our
results suggested remodeling of cartilage could play some role in
the elevated levels of thrombin-cleaved OPN.
There was considerable individual variation in the levels of
thrombin-cleaved OPN detected at 16 and 24 weeks post-PCL
transaction (with some at 8 weeks). Some animals were poten-
tially so different from others for the following reasons. First,
animals were not equally disabled by PCLT, nor they all developed
severe OA at 16 and 24 weeks post-PCL transaction. Identical PCLT
may result in inter-animal variations in instability and OA.
Secondly, the degree of OA development following PCLT may also
vary directly with the degree of biomechanical abnormality
between individuals. Thirdly, a transected PCL can individually heal
spontaneously and did not develop severe OA. Fourthly, the tran-
section of PCL in some animals may be not completed successfully
and result in inter-animal variations in the degree of OA. Therefore,
some animals had lower histological scores at 16 and 24 weeks
post-PCL transaction (with some at 8 weeks) in this study. More-
over, there was correlation between OPN-cleavage levels and
histological scores at these points. Consequently, lower levels of
thrombin-cleaved OPN in these animals were also noted.
Whereas interesting, this is important to pursue these investi-
gations in order to test variations of the biomarker in longer range
studies and in comparison with a control group. Furthermore, it
would be valuable to measure levels of thrombin-cleaved OPN in
serum and urine. Further investigations are under way in our
laboratory to deﬁne the signaling events induced by OPN and
potential experimental strategies for the inhibition of OPN-
mediated OA process. In addition, thrombin has various proin-
ﬂammatory activities and the thrombin level in SF is probably
a feasible marker to monitor ongoing joint inﬂammation33. Based
on the above major point discussed regarding thrombin levels,
measuring thrombin levels in SF from these animals to address
those issues is necessary in the future.
In summary, our results demonstrated that thrombin-cleaved
OPN levels in SF appeared to provide a useful marker of OA
disease severity and progression in this rabbit model of PCLT. This
study added information regarding the validity of thrombin-
cleaved OPN. It should be further studied in human in order to
test their ability to reﬂect the natural course of OA and to complete
our previous study in human7.Contribution
Study design: SGG, LC, GHL; Data acquisition: SGG, WL; Data
analysis: SGG, CZ; Data interpretation: SGG, CZ, FJZ, JT, MT;
Manuscript preparation: SGG, GHL; Manuscript revision: SGG, LC,
WL, GHL.
Conﬂict of interest
No author has any conﬂict of interest related to this work.
Acknowledgments
This work was supported by the National 863 Project of China
(2011AA030101), National Natural Science Foundation of China
(NO. 81201420, 81272034), the Provincial Science Foundation of
Hunan (NO. 09JJ3048), the Young Teacher’s Boosting Project of the
Fundamental Research Funds for the Central Universities in Central
South University, the freedom explore Program of Central South
University (2012QNZT103) and National Clinical Key Department
Construction Projects of China.
References
1. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update
with relevance for clinical practice. Lancet 2011;377(9783):
2115e26.
2. Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D,
Gendreau M, et al. Application of biomarkers in the develop-
ment of drugs intended for the treatment of osteoarthritis.
Osteoarthritis Cartilage 2011;19(5):515e42.
3. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol
Med 2000;11:279e303.
4. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F.
Expression, roles, receptors, and regulation of osteopontin in
the kidney. Kidney Int 2001;60:1645e57.
5. Matsui Y, Iwasaki N, Kon S, Takahashi D, Morimoto J, Matsui Y,
et al. Accelerated development of aging-associated and
instability-induced osteoarthritis in osteopontin-deﬁcient
mice. Arthritis Rheum 2009;60(8):2362e71.
6. Pullig O, Weseloh G, Gauer S, Swoboda B. Osteopontin is
expressed by adult human osteoarthritic chondrocytes:
protein and mRNA analysis of normal and osteoarthritic
cartilage. Matrix Biol 2000;19(3):245e55.
7. Gao SG, Li KH, Zeng KB, Tu M, Xu M, Lei GH. Elevated osteo-
pontin level of synovial ﬂuid and articular cartilage is associ-
ated with disease severity in knee osteoarthritis patients.
Osteoarthritis Cartilage 2010;18(1):82e7.
8. Sharif SA, DuX,Myles T, Song JJ, Price E, LeeDM, et al. Thrombin-
activatable carboxypeptidase B cleavage of osteopontin regu-
lates neutrophil survival and synoviocyte binding in rheuma-
toid arthritis. Arthritis Rheum 2009;60(10):2902e12.
9. Hasegawa M, Segawa T, Maeda M, Yoshida T, Sudo A.
Thrombin-cleaved osteopontin levels in synovial ﬂuid corre-
late with disease severity of knee osteoarthritis. J Rheumatol
2011;38(1):129e34.
10. Shelbourne KD, Davis TJ, Patel DV. The natural history of acute,
isolated, nonoperatively treated posterior cruciate ligament
injuries. A prospective study. Am J Sports Med 1999;27(3):
276e83.
11. Strobel MJ, Weiler A, Schulz MS, Russe K, Eichhorn HJ.
Arthroscopic evaluation of articular cartilage lesions in
posterior-cruciate-ligament-deﬁcient knees. Arthroscopy
2003;19(3):262e8.
12. Kim E, Jeong HJ, Park SJ, Kim DH, Jung YB, Kim SJ, et al. The
effect of intra-articular autogenous bone marrow injection on
S.G. Gao et al. / Osteoarthritis and Cartilage 21 (2013) 144e150150healing of an acute posterior cruciate ligament injury in
rabbits. Arthroscopy 2011;27(7):965e77.
13. Ma Y, Zhang X, Wang J, Liu P, Zhao L, Zhou C, et al. Effect of
bone morphogenetic protein-12 gene transfer on posterior
cruciate ligament healing in a rabbit model. Am J Sports Med
2009;37(3):599e609.
14. Bray RC, Leonard CA, Salo PT. Vascular adaptation of intact
joint stabilizing structures in the posterior cruciate ligament
deﬁcient rabbit knee. J Orthop Res 2003;21(5):787e91.
15. Murao T, Ochi M, Jitsuiki J, Ikuta. The adverse effects of
sectioning the posterior cruciate ligament in rabbits. Changes
in the structural and morphological properties of the femur-
anterior cruciate ligament-tibia complex. Arch Orthop
Trauma Surg 1997;116(1e2):1e5.
16. Tibesku CO, Szuwart T, Ocken SA, Skwara A, Fuchs S. Increase
in the expression of the transmembrane surface receptor
CD44v6 on chondrocytes in animals with osteoarthritis.
Arthritis Rheum 2005;52(3):810e7.
17. Laverty S, Girard CA, Williams JM, Hunziker EB, Pritzker KP.
The OARSI histopathology initiative-recommendations for
histological assessments of osteoarthritis in the rabbit. Oste-
oarthritis Cartilage 2010;18(Suppl 3):S53e65.
18. Yan X, Sano M, Lu L, Wang W, Zhang Q, Zhang R, et al. Plasma
concentrations of osteopontin, but not thrombin-cleaved
osteopontin, are associated with the presence and severity of
nephropathy and coronary artery disease in patients with type
2 diabetes mellitus. Cardiovasc Diabetol 2010;9:70.
19. Ohshima S, Yamaguchi N, Nishioka K, Mima T, Ishii T, Ume-
shita-Sasai M, et al. Enhanced local production of osteopontin
in rheumatoid joints. J Rheumatol 2002;29:2061e7.
20. Petrow PK, Hummel KM, Schedel J, Franz JK, Klein CL, Müller-
Ladner U, et al. Expression of osteopontin messenger RNA and
protein in rheumatoid arthritis: effects of osteopontin on the
release of collagenase 1 from articular chondrocytes and
synovial ﬁbroblasts. Arthritis Rheum 2000;43(7):1597e605.
21. Standal T, Borset M, Sundan A. Role of osteopontin in adhesion,
migration, cell survival and bone remodeling. Exp Oncol
2004;26:179e84.
22. Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, et al. Role of
osteopontin in ampliﬁcation and perpetuation of rheumatoid
synovitis. J Clin Invest 2005;115(4):1060e7.23. Yamamoto N, Sakai F, Kon S, Morimoto J, Kimura C,
Yamazaki H, et al. Essential role of the cryptic epitope SLAYGLR
within osteopontin in a murine model of rheumatoid arthritis.
J Clin Invest 2003;112(2):181e8.
24. Lai CF, Seshadri V, Huang K, Shao JS, Cai J, Vattikuti R, et al. An
osteopontin-NADPH oxidase signaling cascade promotes pro-
matrix metalloproteinase 9 activation in aortic mesenchymal
cells. Circ Res 2006;98:1479e89.
25. Hamada Y, Yuki K, Okazaki M, Fujitani W, Matsumoto T,
Hashida MK, et al. Osteopontin-derived peptide SVVY
GLR induces angiogenesis in vivo. Dent Mater J 2004;23:
650e5.
26. Du J, Hou S, Zhong C, Lai Z, Yang H, Dai J, et al. Molecular basis
of recognition of human osteopontin by 23C3, a potential
therapeutic antibody for treatment of rheumatoid arthritis.
J Mol Biol 2008;382:835e42.
27. Myles T, Leung LL. Thrombin hydrolysis of human osteopontin
is dependent on thrombin anion-binding exosites. J Biol Chem
2008;283(26):17789e96.
28. Gravallese EM. Osteopontin: a bridge between bone and the
immune system. J Clin Invest 2003;112(2):147e9.
29. Kanayama M, Kurotaki D, Morimoto J, Asano T, Matsui Y,
Nakayama Y, et al. Alpha9 integrin and its ligands constitute
critical joint microenvironments for development of autoim-
mune arthritis. J Immunol 2009;182(12):8015e25.
30. Honsawek S, Tanavalee A, Sakdinakiattikoon M,
Chayanupatkul M, Yuktanandana P. Correlation of plasma and
synovial ﬂuid osteopontin with disease severity in knee oste-
oarthritis. Clin Biochem 2009;42:808e12.
31. Okamura N, Hasegawa M, Nakoshi Y, Iino T, Sudo A, Ima-
naka-Yoshida K, et al. Deﬁciency of tenascin-C delays
articular cartilage repair in mice. Osteoarthritis Cartilage
2010;18:839e48.
32. Nakoshi Y, Hasegawa M, Akeda K, Iino T, Sudo A, Yoshida T,
et al. Distribution and role of tenascin-C in human osteoar-
thritic cartilage. J Orthop Sci 2010;15(5):666e73.
33. Kitamoto Y, Nakamura E, Kudo S, Tokunaga H, Murakami E,
Noguchi K, et al. Thrombin in synovial ﬂuid as a marker of
synovial inﬂammation: a deﬁnite measurement by ELISA
and correlation with VEGF. Clin Chim Acta 2008;398(1e2):
159e60.
